HAPLN1 and neoplasm: To explore the effects of HAPLN1 on EMT, stemness and invasion in vivo, we used a model for peritoneal carcinomatosis, injecting RFP and luciferase-expressing KPC and KPC-HAPLN1 cells intraperitoneally (i.p.), to mimic an advanced tumor stage.